3 Scientific Methods, Ethics, and Discovery: Lessons from Psychedelic Research

written by Nicole Ponto & Jennifer Stamp

Learning Objectives

By the end of this section, you will be able to:

  • Describe key developments in the history of psychedelic research and explain how they reflect the evolution of psychological science
  • Evaluate how advances in scientific methods and ethical standards have shaped discoveries in psychedelic research and our understanding of the brain and behaviour.

Wilhem Wundt (Germany) and William James (North America) are credited for founding psychology as a science and academic discipline in the late 1800s. Spanish neuroanatomist Santiago Ramon y Cajal, who was co-awarded a Nobel prize in 1906 for first describing the structure of a neuron, is considered the father of neuroscience.  But scholars have been curious about the mind, brain, and behaviour for thousands of years. Since ancient times, humans have been tinkering with the brains, thoughts, emotions, and behaviours of themselves and others. The Greek philosopher Socrates, for example, worried that writing – a new technology at that time – would diminish people’s ability to remember because they could rely on written records rather than committing information to memory. 

Long before anyone buttoned up a lab coat, curious humans were making discoveries by trying to solve everyday problems. Take drug use, for example. Most drugs we enjoy today are made from plants whose properties, both helpful and harmful, were originally characterized thousands of years ago. Willow bark was used by Indigenous North Americans and ancient Egyptians to treat pain and fever long before the discovery of its active ingredient, salicin, by German pharmacologist Johann Andreas Buchner in 1828. Pharmaceutical giant Bayer modified the structure slightly to make its trademark drug Aspirin, which is one of the most widely used drugs in the world (Werz, 2024). 

Was this wonder drug created in a lab with fancy equipment, or in the field thousands of years before by ordinary people solving problems? The fever-reducing effects of salicin are easy to measure without a thermometer but demonstrating its pain-reducing effects involves tapping into the sufferer’s internal experiences. In modern research studies, it’s usually done using validated questionnaires and rating scales, but you can simply ask someone about their pain experiences before and after taking a drug. Early problem-solvers used similar methods to modern scientists, providing important groundwork for modern use. 

Most of the drugs you’ll learn about in this textbook are psychoactive, meaning they target the nervous system to affect thought, physiology, emotion, and behaviour. These include drugs like alcohol, opioids, cannabis, antidepressants, nicotine, and caffeine. Studying psychoactive drugs scientifically presents unique challenges because researchers need to consider placebo effects and possible harm to participants. Psychedelics, like psilocybin (from magic mushrooms), LSD, mescaline, and ayahuasca, are unique because their powerful effects are primarily manifested as internal changes. These experiences are so profound that they’re often described as mental holidays or “trips” and, unlike other psychoactive drugs, no two trips are the same. Psychologists and neuroscientists, both ancient and modern, have had to grapple with these issues to learn about them. The history of psychedelic research provides a unique example of how our understanding of the brain and behaviour evolves as scientific methods, technologies, and ethical standards change over time. The next section will explore the major waves of psychedelic research and how they reflect broader developments in psychology and neuroscience. For a more detailed history of psychedelics, see the Dig Deeper box at the end of this section.  

Psychedelic Research Through a Modern Scientific Lens 

Human use of psychedelic substances predates modern science, but their systematic study began when researchers started isolating active compounds and investigating their effects using scientific methods. The history of psychedelic research provides an important example of a broader principle in psychology and neuroscience: scientific knowledge is shaped not only by discoveries themselves, but also by the questions researchers ask, the methods they use, and the ethical standards guiding their work. 

The modern scientific study of psychedelics began in 1897 when German pharmacologist Arthur Heffter isolated the naturally occurring alkaloid, mescaline, from the peyote cactus, demonstrating that a specific chemical compound was responsible for its powerful effects on perception and consciousness (Nichols, 2004; Bruhn et al., 2002). Decades later, Albert Hofmann’s discovery of LSD in 1943 sparked widespread scientific interest in using psychedelics as tools for studying perception, consciousness, and subjective experience (Hofmann, 1980). 

Researchers soon began exploring whether these substances could be used therapeutically. Psychiatrist Humphry Osmond investigated LSD as a potential treatment for alcoholism and coined the term psychedelic, meaning “mind-manifesting”, to describe the profound experiences produced by these compounds (Sarett et al., 1966). However, the same period also demonstrated the importance of ethical safeguards in research. At the Allan Memorial Institute in Montreal, psychiatrist Ewen Cameron used LSD in a controversial approach called “psychic driving,” which aimed to replace maladaptive thoughts through repeated messaging after erasing existing memories and personality traits. This involved extreme and often non-consensual procedures, including high doses of LSD, drug-induced comas, prolonged isolation, and intensive electroconvulsive shocks (Cameron, 1956). Many patients experienced lasting psychological harm, and later investigations revealed that Cameron’s work was partly funded by the CIA as part of efforts to study brainwashing techniques (Klein, 2007). Although framed as psychotherapy, these experiments are now recognized as a profound violation of research ethics and patient rights (Torbay, 2023). 

The contrasting work of Osmond and Cameron demonstrates a fundamental lesson in psychology and neuroscience: the same substance can produce very different outcomes depending on how it’s administered. Studying psychedelics scientifically is challenging because their main effects involve subjective experiences that are difficult to measure objectively, like changes in perception, emotion, and consciousness. Early research also revealed the importance of rigorous experimental design, as promising observations must be supported by careful methods before strong conclusions can be drawn. 

By the late 1960s, psychedelics had become associated with counterculture movements and political controversy, leading to increased restrictions on their use (Nutt et al., 2018). The 1970 Controlled Substances Act classified LSD and psilocybin as Schedule I substances, creating major barriers for research and bringing psychedelic science to a near standstill for several decades (Controlled Substances Act, 1970). 

Scientific interest in psychedelics began to re-emerge in the 1990s with improvement in research methods, advancements in neuroscience technologies, and changing attitudes toward drug policy. A key milestone occurred when psychiatrist Rick Strassman received FDA approval to administer dimethyltryptamine (DMT) to human volunteers at the University of New Mexico between 1990 and 1995 – the first approved psychedelic research program in the United States in more than two decades (Strassman, 2001). This renewed period, often called the psychedelic renaissance, demonstrated that psychedelic research could be conducted using rigorous scientific and ethical standards. 

Contemporary studies differ substantially from much of the earlier work. Researchers now rely on randomized controlled trials, standardized psychological measures, and neuroimaging techniques such as fMRI and PET to investigate how psychedelics affect brain function and behaviour (Carhart-Harris et al., 2016). Modern psychedelic-assisted therapy also integrates psychological preparation, professional supervision during the drug experience, and post-session therapeutic support. 

Today, psychedelic-assisted therapy is one of the fastest-growing areas of psychiatric research. Studies are investigating substances such as psilocybin, MDMA, LSD, and ayahuasca as potential treatments for depression, PTSD, substance use disorders, and end-of-life distress (Carhart-Harris & Goodwin, 2017; Reiff et al., 2020). Early findings have been promising, with several clinical trials reporting reductions in depression and psychological distress following psilocybin-assisted therapy (Carhart-Harris et al., 2021; Davis et al., 2021). 

More broadly, the history of psychedelic research illustrates the evolution of psychology and neuroscience as scientific disciplines. Early discoveries generated important questions about the nature of consciousness and the brain, but progress depended on the development of better research methods, more reliable measurement tools, and stronger ethical safeguards. The trajectory of psychedelic science demonstrates a central theme of this chapter: scientific understanding advances when new observations are combined with rigorous methods and ethical responsibility. 

Dig Deeper by Ripley Nolan

From Ancient Rituals to Modern Insights: A Brief History of Psychedelic Science  

Humans have a long history with psychedelic substances. One of the earliest representations is a cave painting from 9000-7000 BCE in the Tassili N’Ajjer region of Algeria (Fig IP.2). It shows human figures holding a local mushroom of the genus Psilocybe, many of which contain the powerful drugs, psilocybin and psilocin. The image shows a connection with dashed lines from each mushroom to the holder’s head, which could represent the effects it has on the brain. Other evidence from the cave suggests that the earliest consumption of psychedelics was closely linked to rituals (Samorini, 2001). We can also speculate that this early exploration was a relatively safe pursuit, because most psychedelic fungi and plants used by ancient humans are low in toxicity (otherwise their use would not continue). 

Figure IP.2 Artwork from Tin-Tazarift rock at Tassili N’Ajjer showing masked human figures holding mushroom-shaped objects. Dotted lines connecting to their heads suggest awareness of psychoactive effects. The dancing posture and masks suggest a religious ceremony. Image source: Samorini (2001).

This section highlights four important lessons learned from early researchers: 

  1. Psychedelics were “special occasion” drugs, restricted to certain people and events.

Psychedelics can be grouped under the term entheogen: a substance, typically a plant or fungus, used in a religious or ceremonial rituals to bring about a spiritual experience. Unlike other psychoactive drug classes, like stimulants, depressants, or opioids, entheogens are defined by their use rather than their specific effects (Winkleman, 2019). Some of the best-known ceremonial psychedelics used by ancient people include psilocybin-containing “magic mushrooms” and mescaline, found in the peyote (Lophophora williansii) and San Pedro (Echinopsis pachanoi) cacti.

The Aztec word for psilocybin-containing mushrooms was teonanácatl, which translates to “flesh of the gods.” Much of what researchers know about these ceremonies and psychedelics come from the Maya religious text the Popol Voh and other sources like the colonial 16th century text, the Florentine Codex (Romero, 2024). This highlights the significance of these entheogenic substances, and the fact that they were “special occasion” drugs that were restricted to certain people and events and were not taken every day.  

In the Mayan culture (250 BCE–900 AD), many group ceremonies were held underground or in caves as those were seen as access points to the underworld. In addition to the darkness and underground setting, the ceremony participants would fast beforehand, and there would be rhythmic music and dancing to strengthen the spiritual experience. Similarly, the Aztecs played music to induce a trance state during ceremonies, particularly drumming, which mimics a heartbeat (Carod-Artal, 2011).  

2. Because of the drug effects and ceremonies that surrounded them, drug trips required companions.  

These drugs were not used recreationally but rather in a controlled setting with experienced “buddies” to ensure the trip had the desired effects. The Florentine Codex includes a description of a social mushroom ceremony between traders where the group ingested psilocybin mushrooms with honey while listening to shell horns being played, drinking only chocolate afterwards, dancing and weeping once the mushrooms took effect, and talking to other participants about their visions, including those who didn’t take the psychedelics (Romero, 2024). There is ample evidence from archaeological and anthropological records depicting people taking this in groups rather than solo. 

According to Harvard University’s Center for the Study of World Religions researcher Osiris Sinuhé González Romero, the common western term, “shaman,” used for those who lead ceremonies is more of a colonial concept. Some Indigenous groups use a word that translates to “the one who sings” (Cox, 2024).  Modern clinical trials for psychedelics borrowed from this practice and provide companion support for participants undergoing therapeutic trips. 

3. The method of ingestion required knowledge of chemistry and pharmacology to get the desired effects while minimizing side effects 

Traditional psychedelic use has been perfected through experimentation of specific preparations and routes of administration. The Maya sometimes used enemas to administer balché, a fermented, slightly alcoholic drink containing psychoactive compounds from the bark of Lonchocarpus longistylus tree. This method avoided the common side effects of nausea and vomiting from drinking it, which happens when passing through the stomach. Many Mayan ceramic vessels featured iconography of people chatting while receiving enemas through a syringe made of clay and gourd (Fig IP.3, Carod-Artal, 2011). This is an example of early pharmacology using experimentation and trial and error, working to optimize the effects and reduce or eliminate side effects.  

Figure IP.3 Ceramic vessel from the Mayan late classic period depicting administration of substances using enemas. (Image source: Carod-Artal, 2011)

4. Psychedelics are, physiologically, amongst the safest of the psychoactive drugs, since there is low potential for overdose. 

Use of entheogens for thousands of years is strong evidence of their safety. If they were physically dangerous, users would have died since there wasn’t any form of overdose control and others probably wouldn’t want to try them. The potential risks for psychedelics are more mental than physical and  there is evidence of positive changes in personality and attitudes, depression and anxiety, spirituality and wellbeing, if used carefully in a supportive environment (Aday, 2020). A controlled group setting guided by an experienced leader for culturally relevant ceremonies provided a psychological safety net with traditional use and informed current clinical therapeutic use of these drugs.

License

Icon for the Creative Commons Attribution 4.0 International License

Introduction to Psychology & Neuroscience (2nd Edition) Copyright © 2020 by Jennifer Stamp; Leanne Stevens; and Kevin LeBlanc is licensed under a Creative Commons Attribution 4.0 International License, except where otherwise noted.